Patrick Bühler
Impact in
-
- Radiopharmaceutical Chemistry and Applications
- Monoclonal and Polyclonal Antibodies Research
- Medical Imaging Techniques and Applications
- Biomaterials top 10%
- Nanoparticle-Based Drug Delivery
Papers in
-
- Radiopharmaceutical Chemistry and Applications 8
- Monoclonal and Polyclonal Antibodies Research 6
-
- Toxin Mechanisms and Immunotoxins 5
- Immunotherapy and Immune Responses 1
- T-cell and B-cell Immunology 1
- Co-authors
- Philipp Wolf (20 shared papers)Ursula Elsässer‐Beile (19 shared papers)Ulrich Wetterauer (12 shared papers)Dorothee Gierschner (10 shared papers)Karen Alt (7 shared papers)Wolfgang Schultze‐Seemann (4 shared papers)Stefan Wiehr (3 shared papers)Bernd Jürgen Pichler (3 shared papers)
- Journals
- The Prostate (6 papers)Cancer Immunology Immunotherapy (2 papers)Journal of Immunotherapy (2 papers)Molecular Pharmaceutics (1 paper)Macromolecular Bioscience (1 paper)
- Partner nations
- GermanyUnited States
In The Last Decade
Patrick Bühler
20 papers receiving 755 citations
Peers
Comparison fields: 5 of 42
- Radiology, Nuclear Medicine and Imaging 381
- Biomaterials 87
- Immunology 123
- Pulmonary and Respiratory Medicine 154
- Oncology 86
Countries citing papers authored by Patrick Bühler
This map shows the geographic impact of Patrick Bühler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick Bühler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick Bühler more than expected).
Fields of papers citing papers by Patrick Bühler
This network shows the impact of papers produced by Patrick Bühler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick Bühler. The network helps show where Patrick Bühler may publish in the future.
Co-authors
The 25 scholars most cited alongside Patrick Bühler, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 85 | |
| 2 | 2009 | 80 | |
| 3 | 2007 | 74 | |
| 4 | 2009 | 71 | |
| 5 | 2009 | 69 | |
| 6 | 2006 | 64 | |
| 7 | 2006 | 43 | |
| 8 | 2010 | 43 | |
| 9 | 2010 | 35 | |
| 10 | 2009 | 34 | |
| 11 | 2010 | 34 | |
| 12 | 2007 | 20 | |
| 13 | 2012 | 20 | |
| 14 | Influence of structural variations on biological activity of anti-PSMA scFv and immunotoxins targeting prostate cancer. | 2010 | 19 |
| 15 | In vivo testing of 177Lu-labelled anti-PSMA antibody as a new radioimmunotherapeutic agent against prostate cancer. | 2011 | 17 |
| 16 | 2014 | 16 | |
| 17 | 2009 | 15 | |
| 18 | Adjuvant intravesical treatment with a standardized mistletoe extract to prevent recurrence of superficial urinary bladder cancer. | 2006 | 12 |
| 19 | 2012 | 11 | |
| 20 | 2010 | 6 |
About Patrick Bühler
Patrick Bühler is a scholar working on Radiology, Nuclear Medicine and Imaging, Immunology, Biomaterials, Pulmonary and Respiratory Medicine and Surgery, having authored 20 papers that have together received 768 indexed citations. Recurring topics across this work include Radiopharmaceutical Chemistry and Applications (8 papers), Monoclonal and Polyclonal Antibodies Research (6 papers), Toxin Mechanisms and Immunotoxins (5 papers), Prostate Cancer Treatment and Research (3 papers), Nanoparticle-Based Drug Delivery (2 papers), Bladder and Urothelial Cancer Treatments (1 paper), Immunotherapy and Immune Responses (1 paper) and T-cell and B-cell Immunology (1 paper). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (381 citations), Biomaterials (87 citations), Immunology (123 citations), Pulmonary and Respiratory Medicine (154 citations) and Oncology (86 citations). Patrick Bühler has collaborated with scholars based in Germany and United States. Frequent co-authors include Philipp Wolf, Ursula Elsässer‐Beile, Ulrich Wetterauer, Dorothee Gierschner, Karen Alt, Wolfgang Schultze‐Seemann, Stefan Wiehr, Bernd Jürgen Pichler, A. Katzenwadel and Nikolaus Freudenberg. Their work appears in journals such as The Prostate, Cancer Immunology Immunotherapy, Journal of Immunotherapy, Molecular Pharmaceutics and Macromolecular Bioscience.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.